PA
ELV icon

Pineridge Advisors’s Elevance Health ELV Stock Holding History

Pineridge Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12
Closed -$4.67K – 490
2025
Q2 		$4.67K Buy
12
+3
+33% +$1.21K ﹤0.01% 312
2025
Q1 		$3.92K Buy
9
+1
+13% +$401 ﹤0.01% 341
2024
Q4 		$2.95K Buy
8
+2
+33% +$837 ﹤0.01% 448
2024
Q3 		$3.12K Sell
6
-10
-63% -$5.34K ﹤0.01% 410
2024
Q2 		$8.67K Buy
16
+10
+167% +$5.29K ﹤0.01% 303
2024
Q1 		$3.11K Sell
6
-24
-80% -$11.9K ﹤0.01% 422
2023
Q4 		$14.1K Buy
+30
New +$13.9K ﹤0.01% 322

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Pineridge Advisors's ELV Position: Q3 2025 in Review

Pineridge Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 12 shares — an estimated $4.67K sold.

Pineridge Advisors first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $14.1K in Q4 2023. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Pineridge Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 12 Elevance Health shares in Q3 2025, an estimated $4.67K.
  • Pineridge Advisors first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Pineridge Advisors's Elevance Health position peaked at $14.1K in Q4 2023.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.